{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:32:12Z","timestamp":1782016332222,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/igc.0b013e31821872f4","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T03:24:35Z","timestamp":1306898675000},"page":"1078-1083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Defining Prognostic Variables in Recurrent Endometrioid Endometrial Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Katharine M.","family":"Esselen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Boruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"del Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Schorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekathryn","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitfield B.","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31821872f4_bb0005","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0010","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/1097-0142(197404)33:4<1108::AID-CNCR2820330433>3.0.CO;2-A","article-title":"Management of the patient with early endometrial carcinoma","volume":"33","author":"Keller","year":"1974","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0015","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1200\/JCO.2001.19.4.1021","article-title":"Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study","volume":"19","author":"Fleming","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0020","doi-asserted-by":"crossref","unstructured":"Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404\u20131411.","DOI":"10.1016\/S0140-6736(00)02139-5"},{"key":"10.1097\/IGC.0b013e31821872f4_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0030","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.2001.19.2.364","article-title":"Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"19","author":"Thigpen","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0040","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0060","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/IGC.0b013e3181a7f71e","article-title":"Management of recurrent endometrioid endometrial carcinoma: an overview","volume":"19","author":"van Wijk","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0065","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ygyno.2008.10.019","article-title":"Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence","volume":"112","author":"Fujimoto","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/gyno.2002.6836","article-title":"Surgical stage I endometrial cancer: predictors of distant failure and death","volume":"87","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0080","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0360-3016(03)00414-0","article-title":"Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy","volume":"56","author":"Jhingran","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0085","first-page":"1977","article-title":"An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer","volume":"20","author":"Gadducci","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Def initive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e31821872f4_bb0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0360-3016(00)00642-8","article-title":"Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy","volume":"48","author":"Jereczek-Fossa","year":"2000","journal-title":"IntJ Radiat Oncol Biol Phys."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:28Z","timestamp":1753233208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24045663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1048891X24045663"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31821872f4","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining Prognostic Variables in Recurrent Endometrioid Endometrial Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31821872f4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}